21 May 2009
The assessment of residual kidney function after living donor nephrectomy
M Bieniasz, A Kwiatkowski, P Domagała, J Gozdowska, R Kieszek, L Ostrowski, A Deptuła, J Trzebicki, M Durlik, L Pączek, A ChmuraAnn Transplant 2009; 14(1): 25-25 :: ID: 880289
Abstract
Background: The number of patients on the waiting list for kidney transplantation is increasing as a result of cadaveric donor's shortage. One of the ways to expand the donor pool is living donor transplantation. However, only 2-3% of kidney transplants in Poland are obtained from the living related donors. The aim of this study was to assess residual renal function and incidence of microalbuminuria in living kidney donors.
Material/Methods: Between 1995 and 2005, 66 living donor open nephrectomies
were performed. Physical examination, blood and urine tests and ultrasonography were performed prior to nephrectomy and at every follow-up visit (every 12 months post-op) in the donors. Donor mean age was 40.9 years (range 29-60). The donors were predominantly female (52.5%). 27 donors did not report for follow-up visits. Observation period ranged from 36 to 156 months.
Results: Mean creatinine concentration increased from 0.89 mg/dl prior to donation to 1.12 mg/dl and 1.1 mg/dl at 36 and 84 months post nephrectomy, respectively. Mean creatinine clearance according to the Cockroft-Gault formula decreased from 94.27 ml/min prior to donation to 80.2 ml/min and 72.2 ml/min at 36 and 84 months post donation, respectively. Microalbuminuria was observed in one patient (2.6%) at 84 months following nephrectomy.
Conclusions: Living kidney donation results in a reduced creatinine clearance in the donor. Follow-up of living kidney donors is essential in determining risk factors for deterioration of residual kidney function.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






